Prevalence and severity of thrombocytopenia in patients with hyperferritinemia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE
    • Publication Information:
      Publication: 2016- : Abingdon : Taylor & Francis
      Original Publication: [Amsterdam] : Newark, NJ : Harwood Academic Publishers ; International Publishers Distributor,
    • Subject Terms:
      Hyperferritinemia*/complications ; Thrombocytopenia*/complications ; Thrombocytopenia*/epidemiology ; Anemia* ; Hematologic Diseases* ; Neoplasms*/complications; Humans ; Retrospective Studies ; Prevalence ; Ferritins
    • Abstract:
      Background: In patients with tumors, inflammation, and blood disorders, hyperferritinemia has been associated with the severity of the underlying disease and is frequently accompanied by a co-occurring low platelet count or thrombocytopenia. Despite this, no established correlation has been identified between hyperferritinemia and platelet count. In this retrospective, double-center study, we sought to describe the prevalence and severity of thrombocytopenia in patients with hyperferritinemia.
      Study and Design: A total of 901 samples were enrolled in this study, all of which had significantly high ferritin levels (>2000 μg/L) between January 2019 and June 2021. We analyzed the general distribution, incidence of thrombocytopenia in patients with hyperferritinemia, and the relationship between ferritin level and platelet count. p -values < 0.05 were considered statistically significant.
      Results: The total incidence of thrombocytopenia in patients with hyperferritinemia was 64.7%. Hematological diseases were the most frequent cause of hyperferritinemia (43.1%), followed by solid tumors (29.5%) and infectious diseases (11.7%). Patients with thrombocytopenia (<150 × 10 9 /L) had significantly higher ferritin levels than those with platelet counts exceeding 150 × 10 9 /L, with median ferritin levels of 4011 and 3221 μg/L, respectively ( P  < 0.001). Additionally, the results showed that the incidence of thrombocytopenia was higher in hematological patients with chronic transfusion than in those without chronic blood transfusions (93% vs 69%).
      Conclusions: In conclusion, our results suggest that hematological diseases are the most common cause of hyperferritinemia and that patients with chronic blood transfusions are more susceptible to thrombocytopenia. Elevated ferritin levels may act as a trigger for thrombocytopenia.
    • Contributed Indexing:
      Keywords: Ferritin; hyperferritinemia; incidence; platelet count; thrombocytopenia
    • Accession Number:
      9007-73-2 (Ferritins)
    • Publication Date:
      Date Created: 20230327 Date Completed: 20230329 Latest Revision: 20230329
    • Publication Date:
      20250114
    • Accession Number:
      10.1080/16078454.2023.2186047
    • Accession Number:
      36971518